126 related articles for article (PubMed ID: 29331149)
21. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC).
Doktorovová S; Araújo J; Garcia ML; Rakovský E; Souto EB
Colloids Surf B Biointerfaces; 2010 Feb; 75(2):538-42. PubMed ID: 19879736
[TBL] [Abstract][Full Text] [Related]
22. Correction to: The effect of Neuroligin-2 absence on sleep architecture and electroencephalographic activity in mice.
Seok BS; Cao F; Bélanger-Nelson E; Provost C; Gibbs S; Jia Z; Mongrain V
Mol Brain; 2019 Jan; 12(1):9. PubMed ID: 30700334
[TBL] [Abstract][Full Text] [Related]
23. Small peptide-modified nanostructured lipid carriers distribution and targeting to EGFR-overexpressing tumor in vivo.
Han C; Li Y; Sun M; Liu C; Ma X; Yang X; Yuan Y; Pan W
Artif Cells Nanomed Biotechnol; 2014 Jun; 42(3):161-6. PubMed ID: 23731383
[TBL] [Abstract][Full Text] [Related]
24. Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers.
Luan J; Zhang D; Hao L; Qi L; Liu X; Guo H; Li C; Guo Y; Li T; Zhang Q; Zhai G
Colloids Surf B Biointerfaces; 2014 Feb; 114():255-60. PubMed ID: 24211416
[TBL] [Abstract][Full Text] [Related]
25. Polyarginine and PEG-AEYLR comodified nanostructured lipid carrier: 10mol% uncleavable PEG-AEYLR showed no shielding effect to polyarginine in vitro while maintaining good tumor targeting in vivo.
Sun M; Zhu Z; Wang H; Jin S; Yang X; Han C; Pan W
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):284-292. PubMed ID: 28355889
[TBL] [Abstract][Full Text] [Related]
26. Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug.
Zhang WL; Gu X; Bai H; Yang RH; Dong CD; Liu JP
Int J Pharm; 2010 May; 391(1-2):313-21. PubMed ID: 20214958
[TBL] [Abstract][Full Text] [Related]
27. Tacrolimus-loaded nanostructured lipid carriers for oral delivery - Optimization of production and characterization.
Khan S; Shaharyar M; Fazil M; Baboota S; Ali J
Eur J Pharm Biopharm; 2016 Nov; 108():277-288. PubMed ID: 27449630
[TBL] [Abstract][Full Text] [Related]
28. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Fang JY; Fang CL; Liu CH; Su YH
Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
[TBL] [Abstract][Full Text] [Related]
29. Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells.
Bondì ML; Botto C; Amore E; Emma MR; Augello G; Craparo EF; Cervello M
Int J Pharm; 2015 Sep; 493(1-2):75-85. PubMed ID: 26211902
[TBL] [Abstract][Full Text] [Related]
30. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
[TBL] [Abstract][Full Text] [Related]
31. The topical administration of rhEGF-loaded nanostructured lipid carriers (rhEGF-NLC) improves healing in a porcine full-thickness excisional wound model.
Gainza G; Bonafonte DC; Moreno B; Aguirre JJ; Gutierrez FB; Villullas S; Pedraz JL; Igartua M; Hernandez RM
J Control Release; 2015 Jan; 197():41-7. PubMed ID: 25449803
[TBL] [Abstract][Full Text] [Related]
32. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.
Rizwanullah M; Amin S; Ahmad J
J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665
[TBL] [Abstract][Full Text] [Related]
33. Development and evaluation of nanostructured lipid carriers of cytarabine for treatment of meningeal leukemia.
Sharma P; Dube B; Sawant K
J Nanosci Nanotechnol; 2011 Aug; 11(8):6676-82. PubMed ID: 22103067
[TBL] [Abstract][Full Text] [Related]
34. Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid.
Silva EL; Carneiro G; Caetano PA; Goulart G; Ferreira Costa D; de Souza-Fagundes EM; Gomes DA; Ferreira LA
Expert Rev Anticancer Ther; 2015 Feb; 15(2):247-56. PubMed ID: 25611812
[TBL] [Abstract][Full Text] [Related]
35. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.
Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S
Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233
[TBL] [Abstract][Full Text] [Related]
36. Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL.
Kampen KR; Sulima SO; Verbelen B; Girardi T; Vereecke S; Fancello L; Rinaldi G; Verbeeck J; Op de Beeck J; Uyttebroeck A; Meijerink JPP; Moorman AV; Harrison CJ; Spincemaille P; Cools J; Cassiman D; Fendt SM; Vermeersch P; De Keersmaecker K
Leukemia; 2019 Apr; 33(4):1055-1062. PubMed ID: 30850735
[TBL] [Abstract][Full Text] [Related]
37. Ubidecarenone-Loaded Nanostructured Lipid Carrier (UB-NLC): Percutaneous Penetration and Protective Effects Against Hydrogen Peroxide-Induced Oxidative Stress on HaCaT Cells.
Wang J; Wang H; Xia Q
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29941831
[TBL] [Abstract][Full Text] [Related]
38. Long circulation nanostructured lipid carriers for gambogenic acid: formulation design, characterization, and pharmacokinetic.
Lin T; Huang X; Wang Y; Zhu T; Luo Q; Wang X; Zhou K; Cheng H; Peng D; Chen W
Xenobiotica; 2017 Sep; 47(9):793-799. PubMed ID: 27618478
[TBL] [Abstract][Full Text] [Related]
39. Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration.
Okonogi S; Riangjanapatee P
Int J Pharm; 2015 Jan; 478(2):726-35. PubMed ID: 25479097
[TBL] [Abstract][Full Text] [Related]
40. Correction: Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent metabolic reprogramming.
Sun S; Liu J; Zhao M; Han Y; Chen P; Mo Q; Wang B; Chen G; Fang Y; Tian Y; Zhou J; Ma D; Gao Q; Wu P
Cell Death Dis; 2019 Sep; 10(10):707. PubMed ID: 31548594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]